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Purpose: Infarct core can expand rapidly in acute stroke patients receiving intravenous tissue plasminogen activator (IV t-PA). We 
investigated changes in the extent of infarct core during IV t-PA treatment, and explored the associative factors of this infarct core 
expansion in patients with proximal artery occlusion.
Materials and Methods: We included patients who were considered for sequential intra-arterial therapy (IAT) due to occlusion of 
intracranial proximal artery after IV t-PA. Patients who had a baseline Alberta Stroke Program Early Computed Tomography (CT) 
Score (ASPECTS) ≥6 and who underwent two consecutive CT scans before and shortly after IV t-PA infusion were enrolled. Pa-
tients were classified into no, moderate, and marked expansion groups based on decreases in ASPECTS (0-1, 2-3, and ≥4, respec-
tively) on follow-up CT. Collateral status was graded using CT angiography.
Results: Of the 104 patients, 16 (15.4%) patients showed moderate and 13 (12.5%) patients showed marked infarct core expansion 
on follow-up CT scans obtained at 71.1±19.1 min after baseline CT scan. Sixteen (15.4%) patients had an ASPECTS value <6 on 
the follow-up CT. None of the patients with marked expansion were independent at 3 months. Univariate analysis and ordinal lo-
gistic regression analysis demonstrated that the infarct core expansion was significantly associated with collateral status 
(p<0.001).
Conclusion: Among patients who were considered for IAT after IV t-PA treatment, one out of every seven patients exhibited 
marked expansion of infarct core on follow-up CT before IAT. These patients tend to have poor collaterals and poor outcomes de-
spite rescue IAT. 
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INTRODUCTION
Intra-arterial therapy (IAT) using a stent retriever is safe and 
effective in acute stroke with intracranial proximal artery oc-
clusion.1-8 However, despite successful reperfusion by IAT, 
some patients do not show clinical improvement. One of the 
plausible explanations for this futile reperfusion is rapid con-
version of ischemic penumbra into irreversible infarct core.9,10 
While patients who already have extensive areas of irrevers-
ible damage are usually excluded from reperfusion therapy,8,11 
some salvageable areas can be converted to irreversible in-
farct core during the reperfusion treatment. However, there 
are few reports on infarct core progression in the hyperacute 
stage in patients with proximal artery occlusion, and its preva-
lence, related factors, and clinical significance are largely un-
known.
Before the efficacy of IAT was proven, IAT was sometimes 
performed as a rescue treatment to patients who do not re-
spond to intravenous tissue plasminogen activator (IV t-PA) 
after follow-up imaging study. By analyzing two consecutive 
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computed tomography (CT) scans acquired before and shortly 
after IV t-PA, we investigated the change in the extent of the in-
farct core during IV t-PA treatment, its associative factors, and 
clinical significance.
MATERIALS AND METHODS
Study population 
We included patients who were potential candidate for IAT 
due to persistent occlusion of intracranial proximal artery after 
IV t-PA (Actilyse, Boehringer-Ingelheim, Ingelheim, Germany) 
and who had two consecutive CT scans before and shortly af-
ter IV t-PA. This group was derived from a cohort that was de-
veloped to investigate the factors associated with thrombus res-
olution after IV t-PA.12,13 In the cohort, two consecutive non-
contrast CT (NCCT) scans were acquired before and shortly 
after IV t-PA infusion in the same scanner (LightSpeed Plus, 
GE Healthcare, Milwaukee, WI, USA or SOMATOM Sensation 
64, Siemens Healthcare, Erlangen, Germany) (Supplementary 
Material, only online), and CT angiography (CTA) was taken 
with follow-up NCCT. For this study, we included patients who 
had unilateral intracranial proximal artery [internal carotid ar-
tery (ICA), middle cerebral artery (MCA) M1, or M2] occlusion 
on CTA between January 2009 and December 2014. We exclud-
ed patients who already had a large infarct core in the initial 
NCCT, indicated by an Alberta Stroke Program Early CT Score 
(ASPECTS) <6. Patients received IV infusion of t-PA within 3 
hours of symptom onset until December 2012 and within 4.5 
hours thereafter. Additional IAT was considered if patients did 
not show a satisfactory clinical response [<50% improvement 
as measured by the National Institutes of Health Stroke Scale 
(NIHSS) score] to IV t-PA infusion.
Image analysis
In this study, infarct core was defined as low-density area on 
NCCT and calculated based on the ASPECTS scoring system. 
ASPECTS was measured with NCCT using revised methodol-
ogy, which does not account for isolated cortical swelling.14 
Patients were classified into three groups: no, moderate, and 
marked expansion groups, defined based on a decrease of 0–1, 
2–3, and ≥4, respectively, in ASPECTS between the two scans. 
The CTA-collateral score (CTA-CS) was measured with recon-
structed maximum intensity projection CTA images as fol-
lows: 0=absence of collateral supply to the occluded vascular 
territory; 1=collateral supply filling <50%, but >0% of the oc-
cluded vascular territory; 2=collateral supply filling >50%, but 
<100% of the occluded vascular territory; and 3=collateral 
supply filling 100% of the occluded vascular territory.15 Two 
stroke neurologists, who were blinded to all clinical informa-
tion, other than the side of the infarction, independently re-
viewed the CT scans and measured ASPECTS and CTA-CS. 
Disagreements between the two readers were resolved by con-
sensus. Good collateral status was defined as CTA-CS ≥2. 
Clinical variables and outcomes
Stroke mechanisms were determined based on the Trial of Org 
10172 in Acute Stroke Treatment (TOAST) classification. The 
initial stroke severity was assessed using the NIHSS, and the 
functional outcome was measured using the modified Rankin 
Scale (mRS) score at 90 days. The degree of reperfusion was 
graded by the Thrombolysis in Cerebral Infarction (TICI) scale 
in the final run of IAT. TICI scales of the patients who did not 
undergo IAT were graded with 24-hour follow-up MR angiog-
raphy. We obtained outcome data and clinical variables, such 
as vascular risk factors, laboratory results, and time metrics, 
from the aforementioned prospective cohort. Successful reper-
fusion was defined as TICI ≥2b, and a favorable outcome was 
defined as mRS ≤2. Symptomatic intracranial hemorrhage 
(ICH) was defined as any hemorrhage associated with neuro-
logical deterioration, as indicated by a decrease of 4 points on 
the NIHSS within 7 days (European Cooperative Acute Stroke 
Study III definition).16 This study was approved by the Institu-
tional Review Board of Severance Hospital (IRB No. 4-2013-
0828), Yonsei University Health System, with a waiver of writ-
ten informed consent from the patients or their qualified next-
of-kin because of the retrospective nature of the study.
Statistical analysis
Values are presented as a number (%), mean±standard devia-
tion (SD), or median [interquartile range (IQR)], as appropriate. 
We compared the baseline characteristics, treatment modali-
ties, time parameters, and imaging characteristics between 
the mild, moderate, and severe infarct expansion groups. Anal-
ysis of variance or Kruskal-Wallis test, χ2 test, and Fisher’s exact 
test were used, as appropriate. The Spearman’s rank correlation 
coefficient was computed between the ASPECTS difference 
and the CTA-CS. Variables achieving p-values less than 0.1 in 
the univariate analyses with an ordinal association and clini-
cally important time variables were adjusted for using multi-
variate analyses (ordinal logistic regression analysis). Univari-
ate analyses (independent sample t-test or Wilcoxon rank sum 
test for continuous variables, and χ2 test or Fisher’s exact test 
for categorical variables) were also performed to compare the 
baseline characteristics, treatment modalities, time parame-
ters, and imaging characteristics between the favorable and 
unfavorable outcome groups. Variables achieving p-values 
less than 0.1 in the univariate analyses for favorable outcomes 
were entered for multivariate analyses (binomial logistic regres-
sion analysis). Inter-rater agreements were assessed using lin-
ear weighted κ statistics. Statistical analyses were performed 
using the R Statistical Software. Results with a two-sided p-val-
ue <0.05 were considered statistically significant.   
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RESULTS
Baseline characteristics 
During the study period, 176 patients in the CT-based throm-
bus imaging cohort received IV t-PA treatment for an anterior 
circulation stroke with serial CT scans acquired before and af-
ter the IV t-PA treatment. After excluding 65 patients without 
proximal artery occlusion on CTA and seven patients with AS-
PECTS ≤6 on initial CT, 104 patients were included for this 
study. The mean age of the study patients was 67.3±10.4 years, 
and 60 (57.7%) of the patients were men. The median NIHSS 
score at admission was 16 (IQR, 13−19). Ninety (86.5%) patients 
were treated with combined IV t-PA and IAT, while 14 (13.5%) 
patients were treated with IV t-PA alone. The reasons for not 
performing IAT despite the presence of occlusion on CTA were 
rapid improvement of clinical symptom in eight patients, ear-
ly ischemic change in more than one third of MCA territory in 
four patients, presence of hemorrhage on follow-up CT in one 
patient, and active tuberculosis in one patient. The primary 
modality used in the IAT was the stent retriever in 52 (57.8%) 
patients, intra-arterial urokinase infusion in 31 (34.4%) patients, 
modified thrombus suction using a Penumbra catheter in 
four (4.4%) patients, and carotid stent placement in three (3.3%) 
patients. Baseline characteristics of the study group appear in 
Table 1. 
Infarct core expansion
Follow-up CT scans were obtained at 71.1±19.1 minutes after 
baseline CT scan. On the follow-up CT scan, 75 (72.1%) pa-
tients showed almost no infarct core expansion. However, 16 
(15.4%) patients showed moderate and 13 (12.5%) patients 
showed marked infarct core expansion (Table 1). Although we 
excluded patients with a baseline ASPECTS <6, there were 16 
(15.4%) patients who had ASPECTS <6 in the follow-up scan 
(Fig. 1). Inter-rater agreements for the expansion of the infarct 
core [linear weighted κ, 0.641; 95% confidence interval (CI), 
0.485−0.797], ASPECTS (linear weighted κ, 0.666; 95% CI, 
0.609−0.723), and CTA-CS (linear weighted κ, 0.625; 95% CI, 
0.530−0.721) were all good. 
Factors associated with infarct core expansion
Univariate analyses revealed an association of the infarct core 
expansion with ICA occlusion, poor collateral status, and se-
vere initial neurological deficits, but not with the time interval 
between the two consecutive CT scans. The proportion of pa-
tients with hypercholesterolemia was significantly higher in 
the moderate expansion group; however, there was no ordinal 
association between the history of hypercholesterolemia and 
infarct core expansion. In the ordinal logistic regression analy-
sis, the infarct core expansion was significantly associated with 
collateral status (odds ratio, 9.232; 95% CI, 4.484−22.209; p< 
0.001) (Table 2). A significant correlation between the differ-
ence in ASPECTS on the consecutive CT scans, and CTA-CS 
(Fig. 2) (Spearman’s rank correlation coefficient ρ=-0.733; p< 
0.001) was also noted. 
Infarct core expansion and clinical outcomes
Fifty eight (55.8%) patients showed a favorable clinical out-
come at 3 months. Infarct core expansion was associated with 
unfavorable clinical outcomes in the univariate (Supplementary 
Table 1, only online) and multivariate analyses after adjusting 
for confounding variables, such as sex, age, prothrombin time, 
time from onset to IV t-PA, initial NIHSS score, initial occlu-
sion site, and successful reperfusion. None of the 13 patients 
with a marked expansion (≥4 point decrease in ASPECTS) of 
the ischemic core were independent at 3 months. In addition, 
only two out of the 16 patients with ASPECTS <6 on the follow-
up CT showed a favorable clinical outcome. Although we could 
not perform multivariate analyses given the low numbers of 
symptomatic ICH and death events within 3 months, a signifi-
cant association between infarct core expansion and symp-
tomatic ICH and death within 3 months was observed in the 
univariate analyses (Table 1).
DISCUSSION
This study investigated the expansion of infarct core during IV 
t-PA treatment in patients with proximal artery occlusion. The 
study showed that 1) infarct core markedly expanded in about 
12% of the patients with proximal artery occlusion at the end 
of IV t-PA infusion, 2) these patients had poor functional out-
comes when they were treated with IAT after the infusion of IV 
t-PA, and 3) poor collaterals were predictive of a marked expan-
sion of the infarct core. 
IAT using a stent retriever is the treatment of choice in pa-
tients with intracranial proximal artery occlusion even if they 
already received IV t-PA treatment based on the recent results 
from randomized controlled trials.2-8 This study simulated the 
situation in which additional IAT is required after IV t-PA treat-
ment, as we included patients who had proximal artery occlu-
sion after IV t-PA. Indeed, the majority of the patients in this 
study population was treated with IAT. In patients who receive 
IAT on top of IV t-PA, IAT is sometimes performed after the in-
fusion of IV t-PA is completed. However, our study demonstrat-
ed that infarct core could expand significantly during this time 
interval in some patients. In this study, 12% of the patients who 
did not have a large infarct core on the initial scan showed 
marked infarct core progression (decrease of ASPECTS ≥4). 
Despite a rescue IAT, none of these patients recovered to an in-
dependent life at 3 months. Although we do not know what the 
prognosis of these patients would be if they were to receive 
IAT as a combined therapy without waiting for completion of 
IV t-PA infusion or follow-up imaging, our results indirectly 
suggest that combined IAT with infusion of IV t-PA should be 
initiated as soon as possible and that patients who are expected 
313
Dongbeom Song, et al.
https://doi.org/10.3349/ymj.2018.59.2.310
Table 1. Baseline Characteristics and Outcomes According to Infarct Core Expansion
Variables Total (n=104)
No expansion 
(n=75)
Moderate expansion 
(n=16)
Marked expansion 
(n=13)
p value
Sex, male 60 (57.7)   44 (58.7)     7 (43.8)      9 (69.2)    0.366
Age (yr)   67.3±10.4   66.1±11.1   71.4±4.62   69.2±10.2 0.137
Hypertension 70 (67.3) 47 (62.7) 13 (81.2) 10 (76.9) 0.314
Diabetes mellitus 26 (25.0) 18 (23.1)   6 (35.3)   3 (23.1) 0.822
Hypercholesterolemia* 9 (8.7) 4 (5.3)   4 (25.0) 1 (7.7) 0.036
Current smoker 19 (18.3)   15 (20.0)   1 (6.3)      3 (23.1)    0.361
Old cerebrovascular accident 32 (30.8)   23 (30.7)     5 (31.2)      4 (30.8)    1.000
Atrial fibrillation 53 (51.0)   34 (45.3)   10 (62.5)     9 (69.2)    0.170
TOAST classification 0.137
Negative evaluation 11 (10.7)   4 (5.41)   4 (25.0)   3 (23.1)
Large-artery atherosclerosis 21 (20.4)   19 (25.7)     1 (6.25)      1 (7.69)    
Cardiac embolism 54 (52.4)   37 (50.0)     9 (56.2)      8 (61.5)    
More than two causes 14 (13.6)   11 (14.9)     2 (12.5)      1 (7.69)    
Other determined   3 (2.91)      3 (4.05)      0 (0.00)      0 (0.00)    
Occlusion site 0.004
ICA 37 (35.6) 19 (25.3)   8 (50.0) 10 (76.9)
M1 46 (44.2)   37 (49.3)     7 (43.8)      2 (15.4)    
M2 21 (20.2)   19 (25.3)     1 (6.25)      1 (7.69)    
Systolic blood pressure (mm Hg) 148.0±27.4   148.5±27.4   148.1±32.1   144.5±22.7   0.891
Hemoglobin (g/dL) 13.8±1.5 13.8±1.6 13.4±1.6 14.3±1.4 0.313
Platelet count (×109/L) 225.8±61.1   228.4±61.4   209.8±73.5   230.9±40.5   0.522
Prothrombin time, international  
  normalized ratio
  0.99±0.10   0.98±0.10   1.00±0.12   1.02±0.10 0.359
Partial thrombin time (sec) 30.1 (6.0) 29.6 (5.2) 32.4 (8.1) 30.3 (6.7) 0.240
Blood sugar level (mg/dL) 137.3±50.8   138.8±54.1 134.4±48.9   131.9±33.5   0.877
Total cholesterol (mg/dL) 167.5±36.8    168±36.5    162±41.3    169±35.7 0.830
Low density lipoprotein (mg/dL)   99.4±32.8 101.2±35.1   91.7±28.5   97.8±24.0 0.622
NIHSS       15.5 [13.0−19.0]       15.0 [11.0−19.0]       15.0 [14.0−20.0]       18.0 [17.0−22.0] 0.015
Initial ASPECTS       9.0 [8.0−10.0]       9.0 [8.0−10.0]         9.0 [8.75−9.25]       9.0 [7.0−10.0] 0.626
Collateral score     2.0 [1.0−3.0]     2.0 [2.0−3.0]     1.0 [1.0−2.0]     0.0 [0.0−0.0] <0.001 
Time from onset to the initial CT (min)   72.2±38.7   73.9±39.2   67.5±37.9   68.0±39.2 0.770
Time from onset to IV t-PA (min)   98.5±38.6 101.0±38.6   91.3±37.8   94.2±41.3 0.619
Time interval between the CTs (min)   71.1±19.1     71.1±19.8     71.1±20.4     71.4±14.1   0.999
Groups based on tPA-eligible time 
  window
0.769
3-hour group 26 (25.0) 19 (25.3)   3 (18.8)   4 (30.8)
4.5-hour group 78 (75.0) 56 (74.7) 13 (81.2)   9 (69.2)
IAT 90 (86.5)   65 (86.7)   15 (93.8)   10 (76.9)   0.462
Stent retriever 52 (57.8)   35 (53.8)   11 (73.3)     6 (60.0)    0.403
Successful reperfusion 75 (72.1)   59 (78.7)   11 (68.8)     5 (38.5)    0.014
Symptomatic ICH   5 (4.81)      2 (2.67)      3 (18.8)    0 (0.0)    0.046
mRS at 3 months 2.0 [1.0−5.0]     2.0 [1.0−3.5] 2.0 [0.75−5.0] 5.0 [4.0−6.0] <0.001 
Favorable outcome at 3 months 58 (55.8)   49 (65.3)     9 (56.2)    0 (0.0)    <0.001 
Death within 3 months 15 (14.4)     8 (10.7)      2 (12.5)      5 (38.5)    0.048
TOAST, Trial of Org 10172 in Acute Stroke Treatment; ICA, internal carotid artery; M1, first segment of the middle cerebral artery; M2, second segment of the middle 
cerebral artery; NIHSS, National Institutes of Health Stroke Scale; ASPECTS, Alberta Stroke Program Early CT score; CT, computed tomography; IV t-PA, intravenous 
tissue plasminogen activator; ICH, intracranial hemorrhage; mRS, modified Rankin Score; IAT, intra-arterial therapy.
Values represent a number (%), mean±standard deviation, or median [interquartile range]. 
*Hypercholesterolemia was defined as 1) fasting cholesterol level >240 mg/dL, 2) fasting low density lipoprotein level >160 mg/dL, or 3) history of taking lipid 
lowering agent due to hypercholesterolemia.
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to have infarct core expansion within an hour may not be an 
ideal candidates for combined IAT. While the poor outcomes 
in patients with infarct core expansion could be due to the 
higher failure of reperfusion in this group, the prognostic ef-
fect of infarct core progression was still significant after adjust-
ing the successful reperfusion in the multivariate analysis. 
We sought to identify factors associated with infarct core ex-
pansion and found that collateral status was one of its main 
associative factors. Collaterals are virtually the only source of 
blood supply in the presence of a proximal artery occlusion.17,18 
Collaterals help the tissues at risk to maintain their viability 
until final reperfusion is achieved. Previous studies have shown 
that the rate of infarct growth is determined by collateral sta-
tus19-21 and that better collateral status in the hyper-acute stage 
is associated with more favorable clinical outcomes.22-24 The 
results of this study are in line with those of previous studies. 
Although the elapsed time would be another factor determin-
ing the infarct core expansion,19,25,26 no definite association 
was observed between time between the two CT scans and 
the infarct core expansion in our study. This might be account-
ed for, in part, by the relatively constant time interval between 
the CTs, with a mean of ~70 minutes and an SD of ~14 minutes 
in this study. Nevertheless, our findings suggest that collateral 
blood supply might be more important than mere time. 
We excluded patients who already have considerable infarct 
core in the initial imaging study (ASPECTS<6) based on recent 
clinical trial results8,11 because the primary aim of this study was 
to evaluate the infarct core expansion after the initial imaging. 
However, it should be acknowledged that the lack of evidence 
for clinical efficacy of IAT in patients with low ASPECTS does 
not necessarily mean that IAT should not be indicated in this 
group of patients. It is also difficult to provide specific sugges-
tions regarding the use of collateral score in selecting an IAT 
candidate with this study because the patients in this study 
received IAT as a rescue therapy after waiting for IV t-PA re-
sponse and that about 40% of the patients were not treated 
with a stent retriever, a currently standard modality of choice 
for IAT.8 
There are several limitations to this study. First, occlusion 
sites and collateral scores were evaluated not in the initial im-
aging studies but in the follow-up studies after t-PA infusion 
because this study population was derived from the cohort for 
CT-based thrombus imaging. Since there is a slight chance of 
clot resolution and dynamic change of collateral status over 
Fig. 1. Distribution of ASPECTS on initial and follow-up CT images. AS-
PECTS, Alberta Stroke Program Early Computed Tomography Score; CT, 
computed tomography.
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Table 2. Ordinal Regression Analysis for Infarct Core Expansion
Variables Odds ratio (95% confidence interval) p value
Collateral score   9.232 (4.484−22.209) <0.001
Occlusion site
M2 Reference
M1   1.730 (0.259−16.666) 0.595
ICA   5.642 (0.891−55.459) 0.091
Time from onset to IV t-PA (min) 0.995 (0.980−1.009) 0.462
Time interval between the CT scans (min) 0.992 (0.963−1.022) 0.610
Initial NIHSS 1.108 (0.964−1.296) 0.167
ICA, internal carotid artery; M1, first segment of middle cerebral artery; M2, second segment of middle cerebral artery; IV t-PA, intravenous tissue plasminogen 
activator; NIHSS, National Institutes of Health Stroke Scale; CT, computed tomography.
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the period of t-PA infusion, this should be considered as a limi-
tation of our study. Second, patients who did not have proxi-
mal artery occlusion after IV t-PA treatment were not included 
in this study. Thus, the findings of this study cannot be applied 
to patients with successful recanalization after IV t-PA or those 
with distal artery occlusions. Third, while about 30% of patients 
had a history of previous stroke, data on pre-stroke mRS were 
not available. Therefore, this should be considered in the in-
terpretation of outcome results. Finally, this study has a mod-
erate sample size and a retrospective single-center design. 
Therefore, generalization of our results must be performed 
with caution.
In conclusion, our study revealed that some patients who 
received IV t-PA showed a rapid expansion of the infarct core 
during IV t-PA infusion, and they showed poor functional out-
comes after rescue IAT. These patients with a rapid expansion 
of infarct core had poor collateral circulations. Our findings 
support the important role of collateral status for maintaining 
tissue viability and suggest that IAT should be started as soon 
as possible without waiting for completion of t-PA infusion.
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